Home Healthcare Pharmaceuticals Intravenous to Subcutaneous Drug Repositioning Market

Intravenous to Subcutaneous Drug Repositioning Market Size, Share & Trends Analysis Report By Product (Devices, Drugs), By Therapeutic Indication (Cardiology, Oncology, Pulmonary Arterial Hypertension, Hematology, Others), By End User (Hospitals & Clinics, Research Facilities, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: March 25, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Intravenous to Subcutaneous Drug Repositioning Market Size Analysis
    1. Introduction
    2. Intravenous to Subcutaneous Drug Repositioning Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Devices
        1. Wearable SC Injectors
        2. Wearable SC Infusers
      2. Drugs
        1. Cancer Drugs
        2. Blood Factors
        3. Immunoglobulin G
        4. Antibiotics
        5. Remodulin
        6. Others
    3. Intravenous to Subcutaneous Drug Repositioning Market Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
      1. Cardiology
      2. Oncology
      3. Pulmonary Arterial Hypertension
      4. Hematology
      5. Others
    4. Intravenous to Subcutaneous Drug Repositioning Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research Facilities
      3. Others
  7. North America Intravenous to Subcutaneous Drug Repositioning Market Size Analysis
    1. Introduction
    2. Intravenous to Subcutaneous Drug Repositioning Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Devices
        1. Wearable SC Injectors
        2. Wearable SC Infusers
      2. Drugs
        1. Cancer Drugs
        2. Blood Factors
        3. Immunoglobulin G
        4. Antibiotics
        5. Remodulin
        6. Others
    3. Intravenous to Subcutaneous Drug Repositioning Market Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
      1. Cardiology
      2. Oncology
      3. Pulmonary Arterial Hypertension
      4. Hematology
      5. Others
    4. Intravenous to Subcutaneous Drug Repositioning Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research Facilities
      3. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
  8. Europe Intravenous to Subcutaneous Drug Repositioning Market Size Analysis
    1. Introduction
    2. Intravenous to Subcutaneous Drug Repositioning Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Devices
        1. Wearable SC Injectors
        2. Wearable SC Infusers
      2. Drugs
        1. Cancer Drugs
        2. Blood Factors
        3. Immunoglobulin G
        4. Antibiotics
        5. Remodulin
        6. Others
    3. Intravenous to Subcutaneous Drug Repositioning Market Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
      1. Cardiology
      2. Oncology
      3. Pulmonary Arterial Hypertension
      4. Hematology
      5. Others
    4. Intravenous to Subcutaneous Drug Repositioning Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research Facilities
      3. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
  9. APAC Intravenous to Subcutaneous Drug Repositioning Market Size Analysis
    1. Introduction
    2. Intravenous to Subcutaneous Drug Repositioning Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Devices
        1. Wearable SC Injectors
        2. Wearable SC Infusers
      2. Drugs
        1. Cancer Drugs
        2. Blood Factors
        3. Immunoglobulin G
        4. Antibiotics
        5. Remodulin
        6. Others
    3. Intravenous to Subcutaneous Drug Repositioning Market Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
      1. Cardiology
      2. Oncology
      3. Pulmonary Arterial Hypertension
      4. Hematology
      5. Others
    4. Intravenous to Subcutaneous Drug Repositioning Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research Facilities
      3. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
  10. Middle East and Africa Intravenous to Subcutaneous Drug Repositioning Market Size Analysis
    1. Introduction
    2. Intravenous to Subcutaneous Drug Repositioning Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Devices
        1. Wearable SC Injectors
        2. Wearable SC Infusers
      2. Drugs
        1. Cancer Drugs
        2. Blood Factors
        3. Immunoglobulin G
        4. Antibiotics
        5. Remodulin
        6. Others
    3. Intravenous to Subcutaneous Drug Repositioning Market Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
      1. Cardiology
      2. Oncology
      3. Pulmonary Arterial Hypertension
      4. Hematology
      5. Others
    4. Intravenous to Subcutaneous Drug Repositioning Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research Facilities
      3. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
  11. LATAM Intravenous to Subcutaneous Drug Repositioning Market Size Analysis
    1. Introduction
    2. Intravenous to Subcutaneous Drug Repositioning Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Devices
        1. Wearable SC Injectors
        2. Wearable SC Infusers
      2. Drugs
        1. Cancer Drugs
        2. Blood Factors
        3. Immunoglobulin G
        4. Antibiotics
        5. Remodulin
        6. Others
    3. Intravenous to Subcutaneous Drug Repositioning Market Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
      1. Cardiology
      2. Oncology
      3. Pulmonary Arterial Hypertension
      4. Hematology
      5. Others
    4. Intravenous to Subcutaneous Drug Repositioning Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research Facilities
      3. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Devices
          1. Wearable SC Injectors
          2. Wearable SC Infusers
        2. Drugs
          1. Cancer Drugs
          2. Blood Factors
          3. Immunoglobulin G
          4. Antibiotics
          5. Remodulin
          6. Others
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Cardiology
        2. Oncology
        3. Pulmonary Arterial Hypertension
        4. Hematology
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Facilities
        3. Others
  12. Competitive Landscape
    1. Intravenous to Subcutaneous Drug Repositioning Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Baxter International
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. United Therapeutics
    3. SteadyMed Therapeutics
    4. CSL Behring
    5. Hoffmann-La Roche Ltd.
    6. Braun Melsungen AG
    7. Fresenius SE & Co. KGaA
    8. Grifols, S.A.
    9. ICU Medical, Inc.
    10. Pfizer Inc. (including Hospira division)
    11. Halozyme Therapeutics, Inc.
    12. Ascendis Pharma A/S
    13. Xeris Biopharma Holdings, Inc.
    14. Alteogen Inc.
    15. Merck KGgA
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.